Outset Medical to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Outset Medical, Inc. (Nasdaq: OM) will release its second-quarter 2021 financial results on August 5, 2021, after market close. CEO Leslie Trigg and Interim CFO Nabeel Ahmed will host a conference call at 2:00 PM PT (5:00 PM ET) on the same day to discuss the results. Outset Medical is known for its innovative Tablo Hemodialysis System, which simplifies dialysis by integrating water purification and on-demand dialysate production, offering a portable solution for patients and healthcare providers.
- Outset's Tablo Hemodialysis System represents a significant technological advancement in dialysis.
- The system allows for greater accessibility and convenience in dialysis care.
- None.
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Interim Chief Financial Officer, will host a conference call to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, August 5, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 7927579. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005885/en/
FAQ
When will Outset Medical release its Q2 2021 financial results?
What time is the Outset Medical conference call?
How can I access the Outset Medical conference call?
What is the Tablo Hemodialysis System?
